Aim: Pneumocystis pneumonia (PCP), caused by Pneumocystis jirovecii (P. jirovecii), is an opportunistic infection with a severe progression, often observed in immunocompromised patients. The diagnosis is difficult due to the non-specific clinical and radiological findings. Therefore, rapid and accurate diagnosis of the agent is important in terms of timely implementation of the treatment. In this study, it was aimed to detect P. jirovecii by Giemsa staining, Modified Toluidine Blue O staining (MTolB), indirect immunofluorescent antibody (IIFA) assay, and real-time polymerase chain reaction (PCR) in clinical samples obtained from patients suspected of having PCP.Material and Methods: Respiratory tract samples (23 oral wash, 19 bronchoalveolar lavage fluid, and eight induced sputum samples) of 50 patients referred to the Microbiology Laboratory of Gazi University Health Application and Research Hospital with the suspicion of PCP were analyzed. The presence of P. jirovecii in the respiratory tract samples was investigated by Giemsa staining, MTolB staining, IIFA (Pneumocell, Cellabs Pty Ltd, Australia), and real-time PCR (the primers targeting the DHFR gene).Results: Of the 50 samples included in the study, four (8%) with MTolB, five (10%) with Giemsa, seven (14%) with IIFA, and seven (14%) with real-time PCR were positive. When real-time PCR was accepted as the gold standard, the sensitivity and specificity values were found to be 85.7% and 97.7%, respectively for IIFA, 71.4% and 100%, respectively for Giemsa and 57% and 100%, respectively for MTolB. There was almost perfect agreement between the results of real-time PCR and IIFA (κ=0.92). In the comparison between PCR and cytochemical staining methods, Giemsa had almost perfect agreement with PCR (κ=0.92) and had a higher coefficient compared to MTolB (κ=0.88). Conclusion: It is considered that it would be more beneficial to use IIFA and real-time PCR tests together in the diagnosis of P. jirovecii.
| dc.contributor.author | Gul, Vahdet | |
| dc.contributor.author | Maharramov, Saleh | |
| dc.contributor.author | Huseynova, Azize | |
| dc.date.accessioned | 2022-03-08T11:41:30Z | |
| dc.date.available | 2022-03-08T11:41:30Z | |
| dc.date.issued | 2020 | |
| dc.department | İnönü Üniversitesi | en_US |
| dc.description.abstract | Aim: This study aims to investigate anthelmintic effect of the essential oil and crude extract of Salvia sclarea L.,Lamiaceae (clary sage), which are widespread in the region of Julfa and Kangarlı districts in Nakhchivan Autonomous Republic. The essential oil was extracted from top flowers and fresh leaves of the plant by ether distillation. Crude extracts were prepared by boiling the dry parts of the plant. Than the extracts were administered separately, in vivo and in vitro targeting on the nematodes localized in the digestive tract of sheep. The results revealed that both extracts have strong anthelmintic effect on nematodes.Material and Methods: The essential oil output of the plant was found to be 0.3-0.4%. The composition of the essential oil was further analyzed by gas chromatography. Total 26 different substances were identified 26 in essential oil extract. Linalylacetate (41.2%) and linalool (18.9%) were found to be the major components of essential oil, extracted from the clary sage.Results: The success in the treatment of nematodes (intensive efficacy) in vivo was 84.3% for essential oil extract, and 69.4% for the crude extract of clary sage species. The extensive efficacies of both products were found to be 60% and 40% respectively. Conclusion: The results confirm that clary sage has high anthelmintic effect in vivo and in vitro on gastrointestinal nematodes in sheep. | en_US |
| dc.identifier.citation | Gul, V., Huseynova, A., & Maharramov, S. (2021). Anthelmintic effect of essential oil and extract produced from Salvia Sclarea L., (Lamiacea) on nematodes living in gastrointestinal system of sheep . Annals of Medical Research, | en_US |
| dc.identifier.uri | https://hdl.handle.net/11616/54785 | |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Annals of Medical Research | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Aim: Pneumocystis pneumonia (PCP), caused by Pneumocystis jirovecii (P. jirovecii), is an opportunistic infection with a severe progression, often observed in immunocompromised patients. The diagnosis is difficult due to the non-specific clinical and radiological findings. Therefore, rapid and accurate diagnosis of the agent is important in terms of timely implementation of the treatment. In this study, it was aimed to detect P. jirovecii by Giemsa staining, Modified Toluidine Blue O staining (MTolB), indirect immunofluorescent antibody (IIFA) assay, and real-time polymerase chain reaction (PCR) in clinical samples obtained from patients suspected of having PCP.Material and Methods: Respiratory tract samples (23 oral wash, 19 bronchoalveolar lavage fluid, and eight induced sputum samples) of 50 patients referred to the Microbiology Laboratory of Gazi University Health Application and Research Hospital with the suspicion of PCP were analyzed. The presence of P. jirovecii in the respiratory tract samples was investigated by Giemsa staining, MTolB staining, IIFA (Pneumocell, Cellabs Pty Ltd, Australia), and real-time PCR (the primers targeting the DHFR gene).Results: Of the 50 samples included in the study, four (8%) with MTolB, five (10%) with Giemsa, seven (14%) with IIFA, and seven (14%) with real-time PCR were positive. When real-time PCR was accepted as the gold standard, the sensitivity and specificity values were found to be 85.7% and 97.7%, respectively for IIFA, 71.4% and 100%, respectively for Giemsa and 57% and 100%, respectively for MTolB. There was almost perfect agreement between the results of real-time PCR and IIFA (κ=0.92). In the comparison between PCR and cytochemical staining methods, Giemsa had almost perfect agreement with PCR (κ=0.92) and had a higher coefficient compared to MTolB (κ=0.88). Conclusion: It is considered that it would be more beneficial to use IIFA and real-time PCR tests together in the diagnosis of P. jirovecii. | en_US |
| dc.type | Article | en_US |
